Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. (Q49068896)

18 February 2018

title

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. (English)

1 reference

18 February 2018

0 references

0 references

1 reference

P Hertel

1

1 reference

18 February 2018

G G Nomikos

series ordinal

2

1 reference

18 February 2018

M Iurlo

series ordinal

3

1 reference

18 February 2018

T H Svensson

series ordinal

4

1 reference

18 February 2018

publication date

1 March 1996

1 reference

18 February 2018

published in

Psychopharmacology

1 reference

18 February 2018

volume

124

1 reference

18 February 2018

issue

1-2

1 reference

18 February 2018

page(s)

74-86

1 reference

18 February 2018

Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02245607

Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245607

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245607

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245607

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245607

Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245607

Thymosthenic agents, a novel approach in the treatment of schizophrenia

21 January 2018

1 reference

12 December 2020

Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients

1 reference

12 December 2020

Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action

1 reference

12 December 2020

Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

1 reference

12 December 2020

The limbic functional selectivity of amperozide is not mediated by dopamine D2 receptors as assessed by in vitro and in vivo binding

1 reference

12 December 2020

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

1 reference

12 December 2020

5-HT2 receptor subtypes: a family re-united?

1 reference

12 December 2020

Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin

1 reference

12 December 2020

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist

1 reference

12 December 2020

Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices

1 reference

12 December 2020

Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs

1 reference

12 December 2020

The risks and benefits of clozapine versus chlorpromazine

1 reference

12 December 2020

Serotonin release estimated by transcortical dialysis in freely-moving rats

1 reference

12 December 2020

Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism

1 reference

12 December 2020

Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain

1 reference

12 December 2020

In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone

1 reference

12 December 2020

Receptor binding properties of amperozide

1 reference

12 December 2020

Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum

1 reference

12 December 2020

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

12 December 2020

Clozapine-associated agranulocytosis: risk and aetiology

1 reference

12 December 2020

Extrapyramidal side effects and tolerability of risperidone: a review

1 reference

12 December 2020

Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo

1 reference

12 December 2020

General pharmacology of clozapine

1 reference

12 December 2020

The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux

1 reference

12 December 2020

In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol

1 reference

12 December 2020

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1 reference

12 December 2020

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

12 December 2020

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex

1 reference

12 December 2020

Biochemical profile of risperidone, a new antipsychotic

1 reference

12 December 2020

Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons

1 reference

12 December 2020

Acute administration of clozapine, thioridazine and metoclopramide increases extracellular DOPAC and decreases extracellular 5-HIAA, measured in the nucleus accumbens and striatum of the rat using in vivo voltammetry

1 reference

12 December 2020

Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia

1 reference

12 December 2020

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system

1 reference

12 December 2020

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors

1 reference

12 December 2020

Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs

1 reference

12 December 2020

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

12 December 2020

Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal cortex by mesencephalic raphe nuclei.

1 reference

12 December 2020

Effects of antipsychotic drugs on serotonin receptors

1 reference

12 December 2020

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients

1 reference

12 December 2020

Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity

1 reference

12 December 2020

The 5-HT2 antagonist ritanserin blocks the effect of pre-frontal cortex inactivation on rat A10 dopamine neurons in vivo

1 reference

12 December 2020

Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.

1 reference

12 December 2020

Changes in single symptoms and separate factors of the schizophrenic syndrome after treatment with risperidone or haloperidol

1 reference

12 December 2020

The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo

1 reference

12 December 2020

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

1 reference

12 December 2020

Risperidone: clinical safety and efficacy in schizophrenia

1 reference

12 December 2020

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

1 reference

12 December 2020

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 reference

12 December 2020

Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

1 reference

12 December 2020

Clozapine--a serotonin antagonist?

1 reference

12 December 2020

Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo

1 reference

12 December 2020

Brain dopamine receptors

1 reference

12 December 2020

Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist

1 reference

12 December 2020

Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach

1 reference

12 December 2020

Effects of antipsychotic drugs on 5-HT2 receptors in the medial prefrontal cortex: microiontophoretic studies

1 reference

12 December 2020

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245607

1 reference

18 February 2018

Dimensions Publication ID

1019395174

0 references

1 reference

18 February 2018